University of São Paulo / Vaccine Development
Advisor: Dr. Jorge Kalil
Lucas develops heat-stable self-amplifying mRNA vaccines suited to low-resource settings, with promising immunogenicity data. His formulation and stability work makes him a strong fit for a vaccine company expanding into emerging markets.
PUBLICATIONS
7
SKILLS
6
ADVISOR
Dr. Jorge Kalil
THESIS TOPIC
Self-amplifying mRNA platforms for thermostable tropical-disease vaccines
SKILLS
TRANSITION SIGNALS
Internship at a vaccine biotech
Filed first patent on a formulation
Co-authored with Butantan Institute scientists
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED